Oxidative stress in cardiovascular disease

Indian Journal of Biochemistry and Biophysics

Volumn 46, Issue 6, 2009, Pages 421-440

  Lakshmi, S V Vijaya ^a   Padmaja, G ^a   Kuppusamy, Periannan ^b   Kutala, Vijay Kumar ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Blood pressure; Cardiovascular diseases; Free radicals; Hypertension; Oxidative stress; Reactive oxygen species

Indexed keywords

FREE RADICAL;

ANIMAL; CARDIOVASCULAR DISEASE; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; REVIEW; COMPLICATION;

ANIMALS; CARDIOVASCULAR DISEASES; FREE RADICALS; HUMANS; OXIDATIVE STRESS;

ANIMALIA;

EID: 77954323861     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (211)

1. Griendling K K, Sorescu D, Lassegue B & Ushio-Fukai M (2000) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20, 2175-2183
2. Suzuki Y J, Forman H J & Sevanian A (1997) Oxidants as stimulators of signal transduction. Free Radic Biol Med 22, 269-285
3. Maulik N & Das D K (2002) Redox signaling in vascular angiogenesis. Free Radic Biol Med 33, 1047-1060
4. Finkel T (1999) Signal transduction by reactive oxygen species in non-phagocytic cells. J Leukoc Biol 65, 337-340
5. Wolin M S (2000) Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol 20, 1430-1442
6. Lassegue B & Clempus R E (2003) Vascular NAD (P) H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285, R277-297
7. Touyz R M & Schiffrin E L (1999) Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34, 976-982
8. Rao G N & Berk B C (1992) Active oxygen species stimulate vascular smooth muscle cell growth and protooncogene expression. Circ Res 70, 593-599
9. Zafari A M, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison D G, Taylor W R & Griendling K K (1998) Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32, 488-495
10. Cosentino F, Sill J C & Katusic Z S (1994) Role of superoxide anions in the mediation of endotheliumdependent contractions. Hypertension 23, 229-235
11. Harrison D G (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100, 2153-2157
12. Kerr S, Brosnan M J, McIntyre M, Reid J L, Dominiczak A F & Hamilton CA (1999) Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 33, 1353-1358
13. Zalba G, San Jose G, Moreno M U, Fortuno M A, Fortuno A, Beaumont F J & Diez J (2001) Oxidative stress in arterial hypertension: role of NAD (P) H oxidase. Hypertension 38, 1395-1399
14. Phan S H, Gannon D E, Varani J, Ryan U S & Ward P A (1989) Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol 134, 1201-1211
15. Holland J A, Pritchard K A, Pappolla M A, Wolin M S, Rogers N J & Stemerman M B (1990) Bradykinin induces superoxide anion release from human endothelial cells. J Cell Physiol 143, 21-25
16. Hsieh C C, Yen M H, Yen C H & Lau Y T (2001) Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells. Cardiovasc Res 49, 135-145
17. Sanders S P, Zweier J L, Kuppusamy P, Harrison S J, Bassett D J, Gabrielson E W & Sylvester J T (1993) Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J Clin Invest 91, 46-52
18. Ballinger S W, Patterson C, Knight-Lozano C A, Burow D L, Conklin C A, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter G C, McIntyre K & Runge M S (2002) Mitochondrial integrity and function in atherogenesis. Circulation 106, 544-549
19. Fleming I, Michaelis U R, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes R P & Busse R (2001) Endotheliumderived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88, 44-51
20. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters B S, Karoui H, Tordo P & Pritchard KA, Jr (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci (USA) 95, 9220-9225 (Pubitemid 28506212)
21. Xia Y, Tsai A L, Berka V & Zweier J L (1998) Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273, 25804-25808
22. Griendling K K, Sorescu D & Ushio-Fukai M (2000) NAD (P) H oxidase: role in cardiovascular biology and disease. Circ Res 86, 494-501
23. Griendling K K, Minieri C A, Ollerenshaw J D & Alexander R W (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74, 1141-1148
24. Zheng J S, Yang X Q, Lookingland K J, Fink G D, Hesslinger C, Kapatos G, Kovesdi I & Chen A F (2003) Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108, 1238-1245
25. Guzik T J, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R & Channon K M (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD (P) H oxidase and endothelial nitric oxide synthase. Circulation 105, 1656-1662
26. Taniyama Y & Griendling K K (2003) Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42, 1075-1081
27. Spiekermann S, Landmesser U, Dikalov S, Bredt M, Gamez G, Tatge H, Reepschlager N, Hornig B, Drexler H & Harrison DG (2003) Electron spin resonance characterization of vascular xanthine and NAD (P) H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 107, 1383-1389
28. Touyz R M & Schiffrin E L (2000) Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52, 639-672
29. Lee S R, Kwon K S, Kim S R & Rhee S G (1998) Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273, 15366-15372
30. Turpaev K T (2002) Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc) 67, 281-292
31. Finkel T & Holbrook N J (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247
32. Berk B C (1999) Protein kinases that mediate redoxsensitive signal transduction. In: Oxidative Stress and Vascular Disease (Keaney J F, ed) pp 335-348, Kluwer Academic Publishers
33. Sundaresan M, Yu Z X, Ferrans V J, Irani K & Finkel T (1995) Requirement for generation of H2O2 for plateletderived growth factor signal transduction. Science 270, 296-299
34. Marrero M B, Schieffer B, Paxton W G, Heerdt L, Berk B C, Delafontaine P & Bernstein K E (1995) Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375, 247-250
35. Chen K, Vita J A, Berk B C & Keaney J F, Jr (2001) c-Jun. N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem 276, 16045-16050
36. Gonzalez-Rubio M, Voit S, Rodriguez-Puyol D, Weber M & Marx M (1996) Oxidative stress induces tyrosine phosphorylation of PDGF alpha-and beta-receptors and pp60c-src in mesangial cells. Kidney Int 50, 164-173
37. Horwitz A R & Parsons J T (1999) Cell migration-movin' on. Science 286, 1102-1103
38. Takemoto M, Sun J, Hiroki J, Shimokawa H & Liao J K (2002) Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106, 57-62
39. Laufs U & Liao J K (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273, 24266-24271
40. Ming X F, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S & Yang Z (2002) Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22, 8467-8477
41. Sawada N, Itoh H, Ueyama K, Yamashita J, Doi K, Chun T H, Inoue M, Masatsugu K, Saito T, Fukunaga Y, Sakaguchi S, Arai H, Ohno N, Komeda M & Nakao K (2000) Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101, 2030-2033
42. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M & Narumiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994
43. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M & Takeshita A (2002) Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105, 1545-1547
44. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S & Takeshita A (2001) Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38, 1307-1310
45. Shimokawa H, Hiramori K, Iinuma H, Hosoda S, Kishida H, Osada H, Katagiri T, Yamauchi K, Yui Y, Minamino T, Nakashima M & Kato K (2002) Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 40, 751-761
46. Noma K, Higashi Y, Jitsuiki D, Hara K, Kimura M, Nakagawa K, Goto C, Oshima T, Yoshizumi M & Chayama K (2003) Smoking activates rho-kinase in smooth muscle cells of forearm vasculature in humans. Hypertension 41, 1102-1105
47. Noma K, Goto C, Nishioka K, Hara K, Kimura M, Umemura T, Jitsuiki D, Nakagawa K, Oshima T, Chayama K, Yoshizumi M & Higashi Y (2005) Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 25, 2630-2635
48. Wolfrum S, Dendorfer A, Rikitake Y, Stalker T J, Gong Y, Scalia R, Dominiak P & Liao J K (2004) Inhibition of Rhokinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24, 1842-1847
49. Ignarro L J, Buga G M, Wood K S, Byrns R E & Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci (USA) 84, 9265-9269
50. Kureishi Y, Kobayashi S, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K & Ito M (1997) Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272, 12257-12260
51. Chen X L & Kunsch C (2004) Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 10, 879-891
52. Rushmore T H, Morton M R & Pickett C B (1991) The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266, 11632-11639
53. Wasserman W W & Fahl W E (1997) Functional antioxidant responsive elements. Proc Natl Acad Sci (USA) 94, 5361-5366
54. Prestera T & Talalay P (1995) Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci (USA) 92, 8965-8969
55. Jaiswal A K (2000) Regulation of genes encoding NAD (P) H:quinone oxidoreductases. Free Radic Biol Med 29, 254-262
56. Alam J, Stewart D, Touchard C, Boinapally S, Choi A M & Cook J L (1999) Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274, 26071-26078
57. Tsuji Y, Ayaki H, Whitman S P, Morrow C S, Torti S V & Torti F M (2000) Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20, 5818-5827
58. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M & Nabeshima Y (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236, 313-322
59. Chan K & Kan Y W (1999) Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci (USA) 96, 12731-12736
60. Bea F, Hudson F N, Chait A, Kavanagh T J & Rosenfeld M E (2003) Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements. Circ Res 92, 386-393
61. Ishii T, Itoh K, Ruiz E, Leake D S, Unoki H, Yamamoto M & Mann GE (2004) Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94, 609-616
62. Buckley B J, Marshall Z M & Whorton A R (2003) Nitric oxide stimulates Nrf2 nuclear translocation in vascular endothelium. Biochem Biophys Res Commun 307, 973-979
63. Chen X L, Varner S E, Rao A S, Grey J Y, Thomas S, Cook C K, Wasserman M A, Medford R M, Jaiswal A K & Kunsch C (2003) Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 278, 703-711
64. Fukai T, Folz R J, Landmesser U & Harrison D G (2002) Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55, 239-249
65. Stralin P, Karlsson K, Johansson B O & Marklund S L (1995) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15, 2032-2036
66. Oury T D, Day B J & Crapo J D (1996) Extracellular superoxide dismutase: a regulator of nitric oxide bioavailability. Lab Invest 75, 617-636
67. Cines D B, Pollak E S, Buck C A, Loscalzo J, Zimmerman G A, McEver R P, Pober J S, Wick T M, Konkle B A, Schwartz B S, Barnathan E S, McCrae K R, Hug B A, Schmidt A M & Stern D M (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561
68. Fichtlscherer S, Breuer S, Schachinger V, Dimmeler S & Zeiher A M (2004) C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease. Eur Heart J 25, 1412-1418
69. Cai H & Harrison D G (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87, 840-844
70. Landmesser U, Dikalov S, Price S R, McCann L, Fukai T, Holland S M, Mitch W E & Harrison D G (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111, 1201-1209
71. Kawashima S (2004) The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Endothelium 11, 99-107 (Pubitemid 39207183)
72. Khan B V, Harrison D G, Olbrych M T, Alexander R W & Medford R M (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci (USA) 93, 9114-9119
73. Janssen-Heininger Y M, Poynter M E & Baeuerle P A (2000) Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28, 1317-1327
74. Hingorani A D (2001) Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 154, 521-527
75. Laursen J B, Somers M, Kurz S, McCann L, Warnholtz A, Freeman B A, Tarpey M, Fukai T & Harrison D G (2001) Endothelial regulation of vasomotion in apoEdeficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103, 1282-1288
76. Durier S, Fassot C, Laurent S, Boutouyrie P, Couetil J P, Fine E, Lacolley P, Dzau V J & Pratt R E (2003) Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation 108, 1845-1851
77. Galis Z S, Sukhova G K, Lark M W & Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94, 2493-2503
78. Foncea R, Carvajal C, Almarza C & Leighton F (2000) Endothelial cell oxidative stress and signal transduction. Biol Res 33, 89-96
79. Ohara Y, Peterson T E & Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91, 2546-2551
80. Franco Mdo C, Fortes Z B, Akamine E H, Kawamoto E M, Scavone C, de Britto L R, Muscara M N, Teixeira S A, Tostes R C, Carvalho M H & Nigro D (2004) Tetrahydrobiopterin improves endothelial dysfunction and vascular oxidative stress in microvessels of intrauterine undernourished rats. J Physiol 558, 239-248
81. Kunsch C & Medford R M (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85, 753-766
82. Marui N, Offermann M K, Swerlick R, Kunsch C, Rosen C A, Ahmad M, Alexander R W & Medford R M (1993) Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92, 1866-1874
83. Chen X L, Zhang Q, Zhao R, Ding X, Tummala P E & Medford R M (2003) Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells. J Pharmacol Exp Ther 305, 573-580
84. Chen X L, Tummala P E, Olbrych M T, Alexander R W & Medford R M (1998) Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83, 952-959
85. Parthasarathy S & Rankin S M (1992) Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res 31, 127-143
86. Torzewski M & Lackner K J (2006) Initiation and progression of atherosclerosis-enzymatic or oxidative modification of low-density lipoprotein? Clin Chem Lab Med 44, 1389-1394
87. Chisolm GM & Steinberg D (2000) The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28, 1815-1826
88. Fruchart J C & Duriez P (1994) Free radicals and atherosclerosis In: Free Radical Damage and its Control (Rice-Evans C A & Burdon R H, eds), pp. 257-281, Elsevier
89. Morel D W, DiCorleto P E & Chisolm G M (1984) Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4, 357-364
90. Biwa T, Hakamata H, Sakai M, Miyazaki A, Suzuki H, Kodama T, Shichiri M & Horiuchi S (1998) Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J Biol Chem 273, 28305-28313
91. Hundal R S, Salh B S, Schrader J W, Gomez-Munoz A, Duronio V & Steinbrecher U P (2001) Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J Lipid Res 42, 1483-1491
92. Steinberg D, Parthasarathy S, Carew T E, Khoo J C & Witztum J L (1989) Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320, 915-924
93. Kim J G, Taylor WR & Parthasarathy S (1999) Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody. Atherosclerosis 143, 335-340
94. Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T & Morooka S (2001) Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 37, 775-779 (Pubitemid 32202444)
95. Inoue T, Uchida T, Kamishirado H, Takayanagi K & Morooka S (2001) Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease. J Am Coll Cardiol 37, 1871-1876 (Pubitemid 32499973)
96. Turrens J F (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552, 335-344
97. Cassina A & Radi R (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 328, 309-316
98. Yakes F M & Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci (USA) 94, 514-519
99. MacMillan-Crow L A, Crow J P & Thompson J A (1998) Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37, 1613-1622
100. Duan J & Karmazyn M (1989) Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Pharmacol 67, 704-709
101. Ballinger S W, Patterson C, Yan C N, Doan R, Burow D L, Young C G, Yakes F M, Van Houten B, Ballinger C A, Freeman B A & Runge M S (2000) Hydrogen peroxideand peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 86, 960-966
102. Tomita H, Egashira K, Kubo-Inoue M, Usui M, Koyanagi M, Shimokawa H, Takeya M, Yoshimura T & Takeshita A (1998) Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Thromb Vasc Biol 18, 1456-1464
103. Wei Y H (1998) Oxidative stress and mitochondrial DNA mutations in human aging. Proc Soc Exp Biol Med 217, 53-63
104. Clayton D A (1984) Transcription of the mammalian mitochondrial genome. Annu Rev Biochem 53, 573-594
105. Corral-Debrinski M, Shoffner J M, Lott M T & Wallace D C (1992) Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 275, 169-180
106. Martinet W, Knaapen M W, De Meyer G R, Herman A G & Kockx M M (2001) Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 88, 733-739
107. Corral-Debrinski M, Stepien G, Shoffner J M, Lott M T, Kanter K & Wallace D C (1991) Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. Jama 266, 1812-1816
108. Knight-Lozano C A, Young C G, Burow D L, Hu Z Y, Uyeminami D, Pinkerton K E, Ischiropoulos H & Ballinger S W (2002) Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105, 849-854
109. Martinet W, Knaapen M W, De Meyer G R, Herman A G & Kockx M M (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106, 927-932
110. Binkova B, Smerhovsky Z, Strejc P, Boubelik O, Stavkova Z, Chvatalova I & Sram R J (2002) DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat Res 501, 115-128
111. Brown M S & Goldstein J L (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52, 223-261
112. Wilcox J N, Subramanian R R, Sundell C L, Tracey W R, Pollock J S, Harrison D G & Marsden P A (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17, 2479-2488
113. Chen X, Touyz R M, Park J B & Schiffrin E L (2001) Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38, 606-611
114. Sharma R C, Hodis H N, Mack W J, Sevanian A & Kramsch D M (1996) Probucol suppresses oxidant stress in hypertensive arteries. Immunohistochemical evidence. Am J Hypertens 9, 577-590
115. Duffy S J, Gokce N, Holbrook M, Huang A, Frei B, Keaney J F, Jr. & Vita J A (1999) Treatment of hypertension with ascorbic acid. Lancet 354, 2048-2049
116. Mullan B A, Young I S, Fee H & McCance D R (2002) Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40, 804-809
117. Kumar K V & Das U N (1993) Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 19, 59-66
118. Touyz R M, Wu X H, He G, Salomon S & Schiffrin E L (2002) Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 39, 479-485
119. Duerrschmidt N, Wippich N, Goettsch W, Broemme H J & Morawietz H (2000) Endothelin-1 induces NAD (P) H oxidase in human endothelial cells. Biochem Biophys Res Commun 269, 713-717
120. Cosentino F, Barker J E, Brand M P, Heales S J, Werner E R, Tippins J R, West N, Channon K M, Volpe M & Luscher T F (2001) Reactive oxygen species mediate endotheliumdependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol 21, 496-502
121. Brigelius-Flohe R, Banning A, Kny M & Bol G F (2004) Redox events in interleukin-1 signaling. Arch Biochem Biophys 423, 66-73
122. Virdis A, Neves M F, Amiri F, Touyz R M & Schiffrin E L (2004) Role of NAD (P) H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22, 535-542
123. Haddad J J (2002) Antioxidant and prooxidant mechanisms in the regulation of redox (y)-sensitive transcription factors. Cell Signal 14, 879-897
124. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone M L, Tacconelli S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso C L, Lechi A, Morganti A & Patrono C (2002) Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106, 2800-2805
125. Lacy F, Kailasam M T, O'Connor D T, Schmid-Schonbein G W & Parmer R J (2000) Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36, 878-884
126. Russo C, Olivieri O, Girelli D, Faccini G, Zenari M L, Lombardi S & Corrocher R (1998) Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16, 1267-1271
127. Schiffrin E L & Touyz R M (2003) Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade. J Am Coll Cardiol 42, 911-913
128. Babior B M, Lambeth J D & Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397, 342-344
129. Berry C, Hamilton C A, Brosnan M J, Magill F G, Berg G A, McMurray J J & Dominiczak A F (2000) Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101, 2206-2212
130. Muzaffar S, Jeremy J Y, Angelini G D, Stuart-Smith K & Shukla N (2003) Role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries. Thorax 58, 598-604
131. Gregg D, Rauscher F M & Goldschmidt-Clermont P J (2003) Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am J Physiol Cell Physiol 285, C723-734
132. Grote K, Flach I, Luchtefeld M, Akin E, Holland S M, Drexler H & Schieffer B (2003) Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD (P) H oxidase-derived reactive oxygen species. Circ Res 92, e80-86
133. Nickenig G, Strehlow K, Baumer A T, Baudler S, Wassmann S, Sauer H & Bohm M (2000) Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression. Br J Pharmacol 131, 795-803
134. Marumo T, Schini-Kerth V B, Fisslthaler B & Busse R (1997) Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96, 2361-2367
135. De Keulenaer G W, Alexander R W, Ushio-Fukai M, Ishizaka N & Griendling K K (1998) Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329 (Pt 3), 653-657
136. Gorlach A, Diebold I, Schini-Kerth V B, Berchner-Pfannschmidt U, Roth U, Brandes R P, Kietzmann T & Busse R (2001) Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22 (phox)-containing NADPH oxidase. Circ Res 89, 47-54
137. Diep Q N, Amiri F, Touyz R M, Cohn J S, Endemann D, Neves M F & Schiffrin E L (2002) PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40, 866-871
138. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer A T, Linz W, Bohm M & Nickenig G (2002) Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 22, 300-305
139. Dandona P, Karne R, Ghanim H, Hamouda W, Aljada A & Magsino C H, Jr (2000) Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. Circulation 101, 122-124 (Pubitemid 30044248)
140. Taddei S, Virdis A, Ghiadoni L, Magagna A, Pasini A F, Garbin U, Cominacini L & Salvetti A (2001) Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens 19, 1379-1386
141. Zalba G, Beaumont F J, San Jose G, Fortuno A, Fortuno M A, Etayo J C & Diez J (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35, 1055-1061
142. Zalba G, San Jose G, Beaumont F J, Fortuno M A, Fortuno A & Diez J (2001) Polymorphisms and promoter overactivity of the p22 (phox) gene in vascular smooth muscle cells from spontaneously hypertensive rats. Circ Res 88, 217-222
143. Zhan C D, Sindhu R K & Vaziri N D (2004) Up-regulation of kidney NAD (P) H oxidase and calcineurin in SHR: reversal by lifelong antioxidant supplementation. Kidney Int 65, 219-227
144. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S & Salvetti A (2003) Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 41, 1281-1286
145. Wyche K E, Wang S S, Griendling K K, Dikalov S I, Austin H, Rao S, Fink B, Harrison D G & Zafari A M (2004) C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 43, 1246-1251
146. Sorescu D & Griendling K K (2002) Reactive oxygen species, mitochondria, and NAD (P) H oxidases in the development and progression of heart failure. Congest Heart Fail 8, 132-140
147. Grocott-Mason R, Anning P, Evans H, Lewis MJ & Shah A M (1994) Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267, H1804-1813
148. Klebl B M, Ayoub A T & Pette D (1998) Protein oxidation, tyrosine nitration, and inactivation of sarcoplasmic reticulum Ca2+-ATPase in low-frequency stimulated rabbit muscle. FEBS Lett 422, 381-384
149. Ferdinandy P, Danial H, Ambrus I, Rothery RA & Schulz R (2000) Peroxynitrite is a major contributor to cytokineinduced myocardial contractile failure. Circ Res 87, 241-247
150. Saavedra W F, Paolocci N, St John M E, Skaf M W, Stewart G C, Xie J S, Harrison R W, Zeichner J, Mudrick D, Marban E, Kass D A & Hare J M (2002) Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 90, 297-304
151. De Biase L, Pignatelli P, Lenti L, Tocci G, Piccioni F, Riondino S, Pulcinelli F M, Rubattu S, Volpe M & Violi F (2003) Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2-production. Thromb Haemost 90, 317-325
152. Heymes C, Bendall J K, Ratajczak P, Cave A C, Samuel J L, Hasenfuss G & Shah A M (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41, 2164-2171
153. Ferrari R, Ceconi C, Curello S, Alfieri O & Visioli O (1993) Myocardial damage during ischaemia and reperfusion. Eur Heart J 14 Suppl G, 25-30
154. Bolli R (1991) Oxygen-derived free radicals and myocardial reperfusion injury. Cardiovasc Drug Therapy 5, 249-268
155. de Lorgeril M, Richard M J, Arnaud J, Boissonnat P, Guidollet J, Dureau
156. Valen G & Vaage J (1993) Toxic oxygen metabolites and leukocytes in reperfusion injury. A review. Scand J Thorac Cardiovasc Surg Suppl 41, 19-29
157. Ambrosio G, Zweier J L, Duilio C, Kuppusamy P, Santoro G, Elia P P, Tritto I, Cirillo P, Condorelli M, Chiariello M & et al (1993) Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 268, 18532-18541
158. Romay C, Armesto J, Remirez D, Gonzalez R, Ledon N & Garcia I (1998) Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res 47, 36-41
159. Garlick P B, Davies M J, Hearse DJ & Slater T F (1987) Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 61, 757-760
160. Zweier J L, Kuppusamy P, Williams R, Rayburn B K, Smith D, Weisfeldt M L & Flaherty J T (1989) Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 264, 18890-18895
161. Khan M, Varadharaj S, Ganesan L P, Shobha J C, Naidu M U, Parinandi N L, Tridandapani S, Kutala V K & Kuppusamy P (2006) C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol 290, H2136-2145
162. Angelos M G, Kutala V K, Torres C A, He G, Stoner J D, Mohammad M & Kuppusamy P (2006) Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol Heart Circ Physiol 290, H341-347
163. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T, Igawa O, Hisatome I & Shigemasa C (2003) Allopurinol improves cardiac dysfunction after ischemiareperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J 67, 781-787
164. Saikumar P, Dong Z, Weinberg J M & Venkatachalam M A (1998) Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17, 3341-3349
165. Guarnieri C & Muscari C (1993) Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology 46, 324-331
166. Weyrich A S, Ma X L & Lefer A M (1992) The role of Larginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86, 279-288
167. Johnson G, 3rd, Tsao P S & Lefer A M (1991) Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19, 244-252
168. Szekeres M, Dezsi L, Monos E & Metsa-Ketela T (1997) Effect of a new nitric oxide donor on the biomechanical performance of the isolated ischaemic rat heart. Acta Physiol Scand 161, 55-61
169. Pomposiello S, Yang X P, Liu Y H, Surakanti M, Rhaleb N E, Sevilla M & Carretero O A (1997) Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition. J Cardiovasc Pharmacol 30, 599-606
170. Prendergast B D, Sagach V F & Shah A M (1997) Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96, 1320-1329
171. Wang P & Zweier J L (1996) Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 271, 29223-29230
172. Beckman J S & Koppenol W H (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271, C1424-1437
173. Liu P, Hock C E, Nagele R & Wong P Y (1997) Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 272, H2327-2336
174. Lin K T, Xue J Y, Sun F F & Wong P Y (1997) Reactive oxygen species participate in peroxynitrite-induced apoptosis in HL-60 cells. Biochem Biophys Res Commun 230, 115-119
175. Kutala V K, Khan M, Mandal R, Potaraju V, Colantuono G, Kumbala D & Kuppusamy P (2006) Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol. J Cardiovasc Pharmacol 48, 79-87
176. Krishna M C, Russo A, Mitchell J B, Goldstein S, Dafni H & Samuni A (1996) Do nitroxide antioxidants act as scavengers of O2-or as SOD mimics? J Biol Chem 271, 26026-26031
177. Gottlieb R A, Burleson K O, Kloner R A, Babior B M & Engler R L (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94, 1621-1628
178. Miller F J, Jr., Gutterman D D, Rios C D, Heistad D D & Davidson B L (1998) Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82, 1298-1305
179. Tan C, Etcubanas E, Wollner N, Rosen G, Gilladoga A, Showel J, Murphy M L & Krakoff I H (1973) Adriamycinan antitumor antibiotic in the treatment of neoplastic diseases. Cancer 32, 9-17
180. Stephanou A, Scarabelli T M, Brar B K, Nakanishi Y, Matsumura M, Knight R A & Latchman DS (2001) Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 276, 28340-28347
181. Zhao Z Q, Nakamura M, Wang N P, Wilcox J N, Shearer S, Ronson R S, Guyton R A & Vinten-Johansen J (2000) Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45, 651-660
182. Greenlund L J, Deckwerth T L & Johnson E M, Jr (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315
183. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R & Latchman D (2001) Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 104, 253-256
184. Yaoita H, Ogawa K, Maehara K & Maruyama Y (1998) Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97, 276-281
185. Mocanu M M, Baxter G F & Yellon D M (2000) Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 130, 197-200
186. Maulik N, Yoshida T, Engelman R M, Deaton D, Flack J E, 3rd, Rousou J A & Das D K (1998) Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem 186, 139-145
187. Hochhauser E, Kivity S, Offen D, Maulik N, Otani H, Barhum Y, Pannet H, Shneyvays V, Shainberg A, Goldshtaub V, Tobar A & Vidne B A (2003) Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. Am J Physiol Heart Circ Physiol 284, H2351-2359
188. Talmor D, Applebaum A, Rudich A, Shapira Y & Tirosh A (2000) Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass. Circ Res 86, 1004-1007
189. Sugden PH & Clerk A (1998) Regulation of mitogenactivated protein kinase cascades in the heart. Adv Enzyme Regul 38, 87-98
190. Yue T L, Wang C, Gu J L, Ma X L, Kumar S, Lee J C, Feuerstein G Z, Thomas H, Maleeff B & Ohlstein E H (2000) Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 86, 692-699
191. Saurin A T, Martin J L, Heads R J, Foley C, Mockridge J W, Wright M J, Wang Y & Marber MS (2000) The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. Faseb J 14, 2237-2246
192. Mackay K & Mochly-Rosen D (1999) An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 274, 6272-6279
193. Ma X L, Kumar S, Gao F, Louden C S, Lopez B L, Christopher T A, Wang C, Lee J C, Feuerstein G Z & Yue T L (1999) Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99, 1685-1691
194. Hausenloy D J, Tsang A, Mocanu M M & Yellon D M (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288, H971-976
195. Liu X, Chua C C, Gao J, Chen Z, Landy C L, Hamdy R & Chua B H (2004) Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286, H933-939
196. Fryer R M, Pratt P F, Hsu A K & Gross G J (2001) Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296, 642-649
197. Zou Y, Zhu W, Sakamoto M, Qin Y, Akazawa H, Toko H, Mizukami M, Takeda N, Minamino T, Takano H, Nagai T, Nakai A & Komuro I (2003) Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury. Circulation 108, 3024-3030
198. Bell R M & Yellon D M (2003) Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. J Mol Cell Cardiol 35, 185-193
199. Okumura H, Nagaya N, Itoh T, Okano I, Hino J, Mori K, Tsukamoto Y, Ishibashi-Ueda H, Miwa S, Tambara K, Toyokuni S, Yutani C & Kangawa K (2004) Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway. Circulation 109, 242-248
200. Takada Y, Hashimoto M, Kasahara J, Aihara K & Fukunaga K (2004) Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J Pharmacol Exp Ther 311, 1249-1255
201. Kutala V K, Khan M, Mandal R, Ganesan L P, Tridandapani S, Kalai T, Hideg K & Kuppusamy P (2006) Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. J Pharmacol Exp Ther 317, 921-928
202. Bagchi D, Das D K, Engelman R M, Prasad M R & Subramanian R (1990) Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-reperfused myocardium. Eur Heart J 11, 800-813
203. Ghosh S, Gifford A M, Riviere L R, Tempst P, Nolan G P & Baltimore D (1990) Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell 62, 1019-1029
204. Jialal I & Devaraj S (2003) Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107, 926-928
205. Patterson C, Madamanchi N R & Runge M S (2000) The oxidative paradox: another piece in the puzzle. Circ Res 87, 1074-1076
206. Stephens N G, Parsons A, Schofield P M, Kelly F, Cheeseman K & Mitchinson M J (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet 347, 781-786
207. Salonen R M, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen T H, Tuomainen T P, Valkonen V P, Ristonmaa U, Lakka H M, Vanharanta M, Salonen JT & Poulsen H E (2003) Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107, 947-953
208. Osganian S K, Stampfer M J, Rimm E, Spiegelman D, Hu F B, Manson J E & Willett W C (2003) Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol 42, 246-252 (Pubitemid 36851413)
209. Pick E & Keisari Y (1980) A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38, 161-170
210. Bernheim F, Bernheim M L & Wilbur K M (1948) The reaction between thiobarbituric acid and the oxidation products of certain lipides. J Biol Chem 174, 257-264
211. Green L C, Wagner D A, Glogowski J, Skipper P L, Wishnok J S & Tannenbaum S R (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126, 131-138